Effect of Riociguat on Bone Metabolism
NCT00855660
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacology, Clinical
Interventions
DRUG:
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg
DRUG:
Placebo
Sponsor
Bayer